These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 8835896)
1. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. Veloso FT; Carvalho J; Magro F J Clin Gastroenterol; 1996 Jul; 23(1):29-34. PubMed ID: 8835896 [TBL] [Abstract][Full Text] [Related]
2. Mucocutaneous manifestations in inflammatory bowel disease. Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896 [TBL] [Abstract][Full Text] [Related]
3. Mucocutaneous manifestations of inflammatory bowel disease in central China -a single-centre study. Kou CX; Zhang YY; Li GW; Li J; Kong QT; Chen J; Liu F; Zhang M; Wang FY; Jiang Y; Hao LY; Ren JA; Sang H J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e211-e212. PubMed ID: 29194792 [No Abstract] [Full Text] [Related]
4. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease. Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379 [TBL] [Abstract][Full Text] [Related]
5. Mucocutaneous manifestations of inflammatory bowel disease in Turkey. Topaloğlu Demir F; Kocatürk E; Yorulmaz E; Adalı G; Kavala M J Cutan Med Surg; 2014 Nov; 18(6):397-404. PubMed ID: 25348761 [TBL] [Abstract][Full Text] [Related]
6. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Bandyopadhyay D; Bandyopadhyay S; Ghosh P; De A; Bhattacharya A; Dhali GK; Das K Indian J Gastroenterol; 2015 Sep; 34(5):387-94. PubMed ID: 26614005 [TBL] [Abstract][Full Text] [Related]
7. Peripheral arthritis in the course of inflammatory bowel diseases. Yüksel I; Ataseven H; Başar O; Köklü S; Ertuğrul I; Ulker A; Dağlı U; Saşmaz N Dig Dis Sci; 2011 Jan; 56(1):183-7. PubMed ID: 20458624 [TBL] [Abstract][Full Text] [Related]
8. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease. Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916 [TBL] [Abstract][Full Text] [Related]
9. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Greenstein AJ; Janowitz HD; Sachar DB Medicine (Baltimore); 1976 Sep; 55(5):401-12. PubMed ID: 957999 [TBL] [Abstract][Full Text] [Related]
10. [Cutaneous manifestations in inflammatory bowel disease]. Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697 [TBL] [Abstract][Full Text] [Related]
11. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease]. Kujundzić M Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969 [TBL] [Abstract][Full Text] [Related]
13. [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis]. Mendoza JL; Lana R; Taxonera C; Alba C; Izquierdo S; Díaz-Rubio M Med Clin (Barc); 2005 Sep; 125(8):297-300. PubMed ID: 16159555 [TBL] [Abstract][Full Text] [Related]
14. The effect of infliximab on extraintestinal manifestations of Crohn's disease. Kaufman I; Caspi D; Yeshurun D; Dotan I; Yaron M; Elkayam O Rheumatol Int; 2005 Aug; 25(6):406-10. PubMed ID: 15309501 [TBL] [Abstract][Full Text] [Related]
15. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study]. Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523 [TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease. Menachem Y; Gotsman I Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Bernstein CN; Blanchard JF; Rawsthorne P; Yu N Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157 [TBL] [Abstract][Full Text] [Related]
18. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. Dotson JL; Hyams JS; Markowitz J; LeLeiko NS; Mack DR; Evans JS; Pfefferkorn MD; Griffiths AM; Otley AR; Bousvaros A; Kugathasan S; Rosh JR; Keljo D; Carvalho RS; Tomer G; Mamula P; Kay MH; Kerzner B; Oliva-Hemker M; Langton CR; Crandall W J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):140-5. PubMed ID: 20453677 [TBL] [Abstract][Full Text] [Related]
19. Dermatologic manifestations in inflammatory bowel disease in Tunisia. Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199 [TBL] [Abstract][Full Text] [Related]
20. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. Halling ML; Kjeldsen J; Knudsen T; Nielsen J; Hansen LK World J Gastroenterol; 2017 Sep; 23(33):6137-6146. PubMed ID: 28970729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]